News

Exsurgo’s Chief Science Advisor, Christine Ozolins, presented a case study of an Axon user at the British Society of Physical and Rehabilitation Medicine (BSPRM) in November 2024, highlighting the promising use of home-based EEG neurofeedback for managing chronic primary pain. The study focuses on a 56-year-old female who had suffered from chronic primary pain for […]

We are thrilled to announce that Exsurgo has been honored as one of the top 100 emerging companies in the UAE, recognized by The Future 100 initiative. This prestigious accolade highlights our commitment to transforming pain management and aligns with our mission to contribute to the competitiveness of future economic sectors. The Future 100 initiative

Exsurgo are please to announce the release of Axon in the UK. Richard Little, Exsurgo Chief Executive says “”When we embarked on the journey to create this product, we were driven by the singular vision of alleviating pain and enhancing the quality of life for millions. Today, we stand at a pivotal moment where that

Exsurgo clincical partner Jon Graham, the Clinical Director of PhysioFunction UK, presented a Case Study of an Axon Patient to the Multidisciplinary Association for Spinal Cord Injury Professionals (MASCIP) conference on the 16th November this year. Read the Case Report

Exsurgo’s Chief Science Officer, Christine Ozilins presernted a Case Report poster at the International Neuromodulation Society conference in Hamburg, Germany that took place in early September this year. Read the Case Report

Exsurgo is proud to work with Homeless Shelter Micah House in Nebraska Read more…

With the tech scene currently booming in New Zealand, and with more and more innovative companies coming up every week, local creative business outlet, Idealog has outlined some of the companies they will be keeping an eye out on in 2023 including our very own Exsurgo. From financial ventures to breakthroughs in the health industry,

Exsurgo has launched new study using EEG neurofeedback as a therapy to manage neuropathic pain in the United Kingdom. Funded by Exsurgo, the new trial is being led by researchers from the East Kent Hospitals University NHS Foundation Trust. Researchers are currently recruiting for ten patients who, over a 22 week period, will wear an

How gamification can support treatment for chronic pain and other neurological conditions Whether it’s smoking, drinking, eating unhealthy food or even mindlessly scrolling through social media, people can’t resist a quick hit of pleasure despite knowing the long-term pitfalls of such behaviour. Through a healthcare lens, this can be dangerous because many of us make

Hi all, We are thrilled to share that our final trialist has completed the Active Neurofeedback Treatment phase of the New Zealand Axon trial in partnership with Auckland University of Technology (AUT) and Waitematā District Health Board (WDHB). As a random Controlled Clinical Trial, it is considered the ‘gold standard’ of clinical trials. The trial